cl001,

Curiously, what made you sell at 1.9+ this morning?

Bought back FNI I sold this morning 1.9+ at ~1.8.

thanks!

Question on alcoholic cases sold? For 9 months there was sales of $4,970,000 on 45,568 cases while for the last three months there were sales of $2,507,236 on 43,337 cases? Can someone explain this?

Thanks!

-------------------------------

Nine Months Ended January 31, 2007 and 2006:

The Company sold Trump Super Premium Vodka for the last four months of the nine months ended January 31, 2007.

Net Sales. Net sales were $5,258,723 for the nine months ended January 31, 2007 compared to net sales of $1,105,700 for the nine months ended January 31, 2006, an increase of 375%. The increase is due to our ongoing business and primarily the launch of Trump Super Premium Vodka which commenced in the last month of the second quarter of fiscal 2007.

The Company launched Trump Super Premium Vodka which is now available throughout 29 states including New England, New York and the rest of the mid-Atlantic states, California, Illinois and we expect to substantially complete US distribution by April 2007. Total Trump Super Premium Vodka sales aggregated $4,252,194 on 39,673 cases sold, which accounted for 80.9% of total dollar sales and 48.7% of total case sales for the nine months ended January 31, 2007. Sales of all alcoholic products aggregated approximately $4,970,000 on 45,568 cases sold for the nine months ended January 31, 2007 as compared to approximately $816,000 on 12,955 cases sold for the nine months ended January 31, 2006. As a result of limited working capital and the focus of a significant portion of our available resources to Trump Super Premium Vodka we did not maintain adequate levels of inventory for certain alcoholic brands which adversely affected their sales in fiscal 2007 and 2006.

Net sales of our non-alcoholic products increased to approximately $329,320 in second half of fiscal 2007 as compared to $289,764 in the first half of fiscal 2006. The increase is due to the increase in sales of Newman's Own Lightly Sparkling Fruit Juices ("Newman's"), which represented the Company's only non-alcoholic product in the first three quarters of fiscal 2007. The Company has improved the Newman's Own products eliminating the high fructose corn syrup and replacing it with pure cane sugar and it is now kosher certified. In addition, we have added lemonade and cherry flavors as well as three varieties of sparkling water. The Company began a national expansion of the Newman's Own product line in the third quarter of our 2007 fiscal year.

Three Months Ended January 31, 2007 and 2006:

Net Sales: Net sales were $2,681,273 for the three months ended January 31, 2007 compared to net sales of $274,880 for the three months ended January 31, 2006. The increase was due to the launch of Trump Super Premium Vodka in second quarter fiscal 2007. Alcoholic product sales were $2,507,236 on 43,337 cases sold for the three months ended January 31, 2007 compared to $210,255 on 2,828 cases for the same period of the prior year. Sales of non-alcoholic products for the three months ended January 31, 2007 were $191,000 on 20,320 cases sold of Newman's Own products compared to $58,560 Newman's on 6,400 cases sold, for the three months ended January 31, 2006. Due to inadequate working capital during this time period we had to strategically de-emphasize certain products. We are now in the process of rebuilding inventories for certain of our products.

In 2005, when this same management bought Petrol Industies, it was a compliant nasdaq stock. Now it is a pink sheet stock and doesn't look like it is going anywhere.

They had the opportunity of merging the Black Dragon assets into Petrol. They did not. Instead they moved assets from PTLD to Black Dragon. Why?

My guess is that they would not have been able to pull off the shenanigans that they have done with the BDGR stock.

The Lanzas control these companies. You guys are crazy to think that the new CFO at BDGR doesn't do what the Lanzas want.

All the common stock that is held by the public doesn't hold a candle to the voting rights and company ownership of the preferreds. Who owns the preferreds? That's a good question.

I understand about the par value. Question still remains about the particulars of who owns them and how many of the perferred shares exist and what do the preferred shares confer to the owner.

Doesn't it make it curious that the par value of the common is 58K while the preferred par is 4+ million?

What about the preferred shares?

I hate to keep bringing this up, but the preferreds far outnumber the common. I don't know the exact composition of the perferreds, but you can get a clue with the last Unaudited Financials SHAREHOLDER EQUITY SECTION:

 
 Shareholders Equity             12/31/05         09/30/06 
 Common Stock                      21,398           58,293 
 Preferred Stock                4,344,651        4,344,651 
 

Don't forget to get the complete, fully diluted share structure including regular shares authorized and outstanding and the various other classes of shares, preferred shares, or convertible preferred shares.

Lanza companies usually have convertible preferred shares issued to management and other controlling individuals that, when converted, result in super majority voting rights.

bubba:

can you help we with a couple of questions regarding BDGR and SONRIS data.

1) Who is the operator for Black Dragon?

2) I could not find the "Hosston Field" in Caddo Parish within SONRIS.

From
Black Dragon Acquires 19 Oil and Gas Wells; 914 Acres in Hosston Field, Caddo Parish, Louisiana

AUSTIN, Texas, Aug 03, 2006 (BUSINESS WIRE) -- Black Dragon Resource Companies, Inc. (OTCPK: BDGR) announced today the acquisition of six oil and gas leases comprising 914 acres of mineral rights and 19 existing oil wells in the Hosston Field, Caddo Parish, Louisiana. The purchase was achieved with restricted common stock and cash.

HLSH will be applying for relisting after the 2Q 10Q. It should be relisted on NYSE or NASDAQ by 3Q-4Q. I'm betting on NYSE.

There is a good group of HLSH investors on InvestorVillage.com at http://www1.investorvillage.com/smbd.asp?mb=134&pt=m

Don't pluck so fast.... :)

http://www.snopes.com/language/apocryph/pluckyew.htm

http://www.snopes.com/language/acronyms/fuck.htm

False warning about cell phones.

See http://www.snopes.com/politics/business/cell411.asp

and http://www.ftc.gov/opa/2005/04/dnc.htm



JUST A REMINDER...8 days from today, all cell phone numbers are being released to telemarketing companies and you will start to receive sales calls. YOU WILL BE CHARGED FOR THESE CALLS.... To prevent this, call the following number from your CELL phone:

fasteddie:

I bought my first shares in TCLL at 0.12. Then was excited to see the run going over 0.20. Bought some more at 0.22. Saw the run top at 0.27 and begin the fall back, all the way to 0.10. I'm still here at 0.24 and waiting for the next push.

My point is that these stocks will go up and then retrace. Hang on for the moves and this stock should reward.

I can't afford any more good news.... :(

LOL

Real-time level II is available free for OMOG here:
http://www.pinksheets.com/quote/quote.jsp?symbol=omog

"comon this company is so gooooood, why isn't anyone pickin' off my shares at .10?"

I'm waiting for you to sell them to me for 0.06

The growth in sales was not as good as I was expecting, especially considered the additional days in March.

The growth in the Hold Journal seems good.

Were they making the move to the new building in March?

MEDirect Latino Inc. Exceeds One Million Dollars in March Revenues

Tuesday April 11, 4:05 pm ET
Revenues Increase 11 Percent over February to $1,002,391, New Client Shipments Increase 20 Percent to 4,421

PLANTATION, Fla., April 11, 2006 (PRIMEZONE) -- MEDirect Latino Inc. (Other OTC:MLTO.PK - News) (http://www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced record results for March 2006 in gross billings and new patient shipments. MEDirect Latino reports gross billings of $1,002,391 during the month, a 10.52% increase over February's billings of $906,936. The Company's gross product profit margins remained unchanged at 78%. Total new patient shipments for March numbered 4,421, an increase of 20.39% over February's shipments of 3,672. The Company's 'patient hold journal' (approved and pending shipment for regulatory processing), closed the month with 5,203 additional customer orders, an increase of 17% over February's 4,447 patient hold journal. MEDirect Latino expects to monetize its approved and pending patient orders in April, which is typical to the Company's model.

Ms. Debra Towsley, President, MEDirect Latino, stated, ``MEDirect Latino continues to show record monthly increases in all phases of our operations. The Company has reached a milestone in surpassing a million dollars per month in revenue, all in less than six months from when we began our national advertising campaign. Our continued record growth is a direct result of the efforts of all our employees, who exhibit great pride in providing exemplary customer care. MEDirect Latino has proven results which are consistent in changing markets and economic conditions. Our marketing strategy is simple in its execution: we identified the customers; we reached them; and the customers responded overwhelmingly. That is the true measure of any successful media and marketing campaign. The success of our business is in the large number of customers we are currently servicing on a recurring basis, and the beneficiaries who are migrating to MEDirect Latino due to our Hispanic-friendly Medicare model.''

I wish someone would pay me $150,000 to make a book report on a company. Sheesh.

If we all ignored him, no need to go premium....

doubloon:

As far as the buyout comments, Ron Williams did say that in the last CC; although the numbers were more like $20-25.

8KA info:

Item 4.01 Changes in Registrant’s Certifying Accountant.
On February 16, 2006, the Board of Directors of Tricell, Inc., a Nevada corporation (the “Company”), unanimously resolved to dismiss Berenfeld, Spritzer, Schechter and Sheer, Certified Public Accountants (“BSS&S”) as the Company’s independent auditor.
During the past two years, the reports of BSS&S on the Company’s financial statements did not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles.
During the Company’s two most recent fiscal years and any subsequent interim period preceding such dismissal there were no disagreements between the Company and BSS&S on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure which, if not resolved, would have caused BSS&S to make reference to the subject matter of the disagreement in connection with its reports.
The Company has furnished BSS&S with a copy of this Form 8-K and has requested that BSS&S furnish a letter to the Commission stating whether it agrees with the above statements. BSS&S's letter is attached to this amended 8-K as exhibit 16.
On February 16, 2006, the Board of Directors of the Company unanimously resolved to engage Whitley Penn as the Company’s independent auditor for the fiscal year ended December 31, 2005.

Item 9.01 Financial Statements and Exhibits.
The Exhibit Index preceding the exhibits is incorporated herein by reference.
SIGNATURES
Pursuant to the requirement of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated this 7th day of March 2006.

TRICELL, INC.



By: /s/ Neil Pursell



Neil Pursell,

Chief Financial Officer

2



EXHIBIT INDEX

Exhibit No. Page
Description of Exhibit
16
4 Letter from Berenfeld, Spritzer, Schechter and Sheer, dated March 7, 2006.

3



EXHIBIT 16
March 7, 2006
Securities and Exchange Commission
Division of Corporate Finance
450 Fifth Street, N.W.
Washington, D.C. 20549
Gentlemen:
We have read item 4.01 of Amended Form 8-K, dated March 7, 2006, of Tricell, Inc. and are in agreement with the statements contained herein.
Very truly yours,


/s/ Berenfeld, Spritzer, Schechter and Sheer



Berenfeld, Spritzer, Schechter and Sheer,

Certified Public Accountants

Monthly Summary

Date                Jul-05   Aug-05  Sep-05  Oct-05  Nov-05  Dec-05  Jan-06  Feb-06 
 Gross Billings       83658   145984  304621  418406  540114  596717  804949  906936 
 % Change Prio Month            75%     109%     37%     29%     10%     35%     13% 
 New Patients                   638     1304    1561    2030    2441    3186    3672 
 ross Profit Margins     68      74       74      77      77      78      78      78 
 Patient Hold Journal                                           3213    4106    4447 
 

allowance for doubtful accounts receivable:

MLTO did comment at the last CC about this issue. I had summarized the CC in this message.
http://www.investorshub.com/boards/read_msg.asp?message_id=9631683

What I had there was this:
Reserve for doubtful accounts
Currently allocating 7% of revenue to doubtful accounts, but actually less than that.
Initial figures were very high because auditors requested all copay (20%) be allocated as doubtful, as given in the early numbers from June-Sept 2005.

I have an email out to MLTO for further clarification regarding the quarterly report.

Good find.

Big question is when that was written, i.e. recently or before ACE Telcom.

The whole text on that page is good:
TRICELL ‘s strategic objectives given the potential volatility of trading and the increasingly uncertain regulatory environment (the implications of the UK recent Budget announcement on the recovery of VAT on mobile phone trading are still not clear) are:

* To diversify its product range - building on its leading position in the wholesale sale and distribution market of handsets: initially by expanding its range of products to cover the full range of mobile accessories from hands free kits, cameras to mobile phone kits, headsets, ring tones, batteries etc. and expanding its range of wholesale customers geographically

* To use its new status as a publicly quoted company to acquire, where opportunities arise at the right price, portfolios of retail outlets from existing retailers to provide the wholesale business with an “in-house” distribution channel to the end user

* To broaden the product range into the provision of telecoms services initially based on purchasing and selling airtime in the wholesale market.

* To acquire market share through acquisitions of competitors in the wholesale market

* To increase its net pre-tax margin from 1.4% to 1.75% by mixture of improved product mix and the benefits of removing the central cost bases of the company acquisitions

The first three acquisitions (two in the UK and one in Eire) have been identified, and negotiations to acquire the businesses are in the final stages of completion. Total annual revenues being acquired are in excess of £300 million sterling. The consideration will be a mixture of cash, loan notes and a limited issue of ordinary shares. The objective being to drive the earnings per share of Tricell Inc.

Everyone waiting on the audit? LOL

Hope this new firm can get this together by 03-30

angelhillcorp:

So, how has your comfort factor changed with this company over the past couple of weeks?

I don't think so.

I think now what is holding it back is trading in the pinks and lack of visibility.

They are certainly unaudited numbers.

The last audited information from MLTO is the Form 4 that was recently filed.

Even the upcoming 10Q will likely be unaudited, as the only form that is required to be audited by the SEC is the annual 10K.

They expect to be revising the numbers for the year up again very soon.

Read this post, my summary of the last conf. call: http://www.investorshub.com/boards/read_msg.asp?message_id=9631683

In addition to chillin102's list, the company will be running commercials and taking calls seven days per week, not just M-F.

thanks, angelhill!

Form 10 Link: http://www.sec.gov/Archives/edgar/data/1203018/000110801706000118/ml1012g.htm

OTCLive.com report for MLTO: http://www.otclive.com/MLTO_Report.pdf

MLTO: Just listened to the call. Lots of info. If you have not listened, you should to get a feel for this company.

Background of MEDirect Latino, target demographics:
http://medirectlatino.org/pdf/MEDirect%20Latino%20Fast%20Facts.pdf

Highlights of what I heard:

Products:
Medicare reimbursed medical products including diabetic monitoring equipment and supplies, COPD, and other chronic diseases.
Medicare pays 80%, customer 20%.
Customer orders quarterly.
Currently sells about $1300-1400 per year per customer with current products.
Introduced accessories (heating pads, seat lift assists, canes & walkers) and are seeing 80% penetration into database of customers. 11,000 other Medicare reimbursable products.
Future products include pharmaceuticals.

Number of Customers:
Currently: 20,000
by FY 06/2006: 53-54,000
by YE 12/2006: 87-88,000
by FY 06/2007: 144,000

Customers order about 1300-1400 per year.
Current customer retention rate is 98-99%. Industry is 85%-87%. MLTO has projected 3-4% in its estimates.

Marketing:
No other diabetic direct marketer targets the Latino market.

MLTO target markets the Latino market by advertising on TV with Univision and Telemundo, both Spanish language channels along with Spot TV, cable, print ads, billboards, etc.
Will soon be making more educational commercials and commercials with a female latin celebrity. (I think it will be Rita Moreno.) http://www.allamericanspeakers.com/newspeakerbio/1381/index.php


Current TV budget is 10.6 million for 2006. Will be able to spread these costs over 3 years, due to accounting ruling. This will significantly boost EPS, but not taking the full hit up front.

Customer Service:
Good customer service is responsible for enrolling and retaining customers. Reorders are far less expensive than initial acquisition costs. Good quality, Spanish-speaking customer service representatives are a big advantage.

Expanding into closed-door pharmacies. One in California; letter of intent already signed. This will give MLTO access to Medi-Cal (A California state Medicare) Another state pharmacy not finalized yet. (could it be NY?)

Currently working two shifts Monday-Friday in 6000 sqft Plantation warehouse/office. Will be signing lease for 23,600 sqft office location on 02/09/06.
Hired 32 customer service reps in Jan and continue to hire.
Second shift accounting for 750 sales per week (3000 per month)
Two people in Puerto Rico for direct marketing to 1500-1800 doctors offices.
Moving to a seven day work week, not just M-F. This means more TV spots for Sat/Sun.

Management:
Current management has been working very hard for the past two years, some wearing two-three hats. Need to add upper management as company grows. Actively seeking candidates.

MLTO started selling in Puerto Rico in March 05. Went national in Sept 05.

Already approached by 3rd parties for acquisition or mergers. Not willing to sell cheap, so early in development cycle.

Management's goal is to be committed to enhance shareholder value

Will be hiring investment banker to enhance shareholder value.

Currently MLTO is debt free.

MLTO was looking at additional financing (selling shares, etc) around $10mm, but reduced that to $6.5mm, and now may consider a far smaller number due to the tremendous cash flow being generated by current business. May not even need such additional financing.

Currently there are 17mm fully diluted shares, with 60% owned by management and insiders.

MLTO recently in January increased the estimated guidance for 2006 and are getting ready to increase estimates again.

Valuing MEDirect Latino
Ron Williams of TBeck Capital, an initial investor of MLTO spoke on valuation of the company.
Using PE valuation: Estimated share count of 18mm (1mm more than actual), and using a comparitive PE of a competitor, PolyMedica, of 39.
Current revenue and earnings projection for FY2006(06/06) is 21mm rev and 4.6mm net income. So 4.6mm net income / 18mm shares x 39 = $10
Current revenue and earnings projection for FY2007(06/07) is 124mm rev and 59mm net income. Using a forward PE of 20. So 59mm net income / 18mm shares x 20 = $65.
Remember that MLTO is going to up guidance for FE2006.
MLTO is worth far more than $10 and something less that $65, as FY2007 is a long way way.

Using Value per client: Industry practice is value based on 3-4 year revenue from customer. Industry is usually 3000-3500. MLTO thinks their customer is valued at 5000.
FY2006 customer count of 52,000 gives a market cap of 260mm. 260mm/18mm = $12.50
YE2006 (12/06) customer count of 72,000 gives a market cap of 360mm. 360mm/18mm = $20
FY2007 (06/07) customer count of 144,000 gives a market cap of 720mm. 720mm/18mm = $40

Market Share
At FY2006, looking to see 3%.
Mgmt and shareholders should expect 8-10% (400,000)

Reserve for doubtful accounts
Currently allocating 7% of revenue to doubtful accounts, but actually less than that.
Initital figures were very high because auditors requested all copay (20%) be allocated as doubtful, as given in the early numbers from June-Sept 2005.




Wow. Lots of stuff to digest.
Hope this helps. It sure helped me. :)

Just listened to the call. Lots of info. If you have not listened, you should to get a feel for this company.

Background of MEDirect Latino, target demographics:
http://medirectlatino.org/pdf/MEDirect%20Latino%20Fast%20Facts.pdf

Highlights of what I heard:

Products:
Medicare reimbursed medical products including diabetic monitoring equipment and supplies, COPD, and other chronic diseases.
Medicare pays 80%, customer 20%.
Customer orders quarterly.
Currently sells about $1300-1400 per year per customer with current products.
Introduced accessories (heating pads, seat lift assists, canes & walkers) and are seeing 80% penetration into database of customers. 11,000 other Medicare reimbursable products.
Future products include pharmaceuticals.

Number of Customers:
Currently: 20,000
by FY 06/2006: 53-54,000
by YE 12/2006: 87-88,000
by FY 06/2007: 144,000

Customers order about 1300-1400 per year.
Current customer retention rate is 98-99%. Industry is 85%-87%. MLTO has projected 3-4% in its estimates.

Marketing:
No other diabetic direct marketer targets the Latino market.

MLTO target markets the Latino market by advertising on TV with Univision and Telemundo, both Spanish language channels along with Spot TV, cable, print ads, billboards, etc.
Will soon be making more educational commercials and commercials with a female latin celebrity. (I think it will be Rita Moreno.) http://www.allamericanspeakers.com/newspeakerbio/1381/index.php


Current TV budget is 10.6 million for 2006. Will be able to spread these costs over 3 years, due to accounting ruling. This will significantly boost EPS, but not taking the full hit up front.

Customer Service:
Good customer service is responsible for enrolling and retaining customers. Reorders are far less expensive than initial acquisition costs. Good quality, Spanish-speaking customer service representatives are a big advantage.

Expanding into closed-door pharmacies. One in California; letter of intent already signed. This will give MLTO access to Medi-Cal (A California state Medicare) Another state pharmacy not finalized yet. (could it be NY?)

Currently working two shifts Monday-Friday in 6000 sqft Plantation warehouse/office. Will be signing lease for 23,600 sqft office location on 02/09/06.
Hired 32 customer service reps in Jan and continue to hire.
Second shift accounting for 750 sales per week (3000 per month)
Two people in Puerto Rico for direct marketing to 1500-1800 doctors offices.
Moving to a seven day work week, not just M-F. This means more TV spots for Sat/Sun.

Management:
Current management has been working very hard for the past two years, some wearing two-three hats. Need to add upper management as company grows. Actively seeking candidates.

MLTO started selling in Puerto Rico in March 05. Went national in Sept 05.

Already approached by 3rd parties for acquisition or mergers. Not willing to sell cheap, so early in development cycle.

Management's goal is to be committed to enhance shareholder value

Will be hiring investment banker to enhance shareholder value.

Currently MLTO is debt free.

MLTO was looking at additional financing (selling shares, etc) around $10mm, but reduced that to $6.5mm, and now may consider a far smaller number due to the tremendous cash flow being generated by current business. May not even need such additional financing.

Currently there are 17mm fully diluted shares, with 60% owned by management and insiders.

MLTO recently in January increased the estimated guidance for 2006 and are getting ready to increase estimates again.

Valuing MEDirect Latino
Ron Williams of TBeck Capital, an initial investor of MLTO spoke on valuation of the company.
Using PE valuation: Estimated share count of 18mm (1mm more than actual), and using a comparitive PE of a competitor, PolyMedica, of 39.
Current revenue and earnings projection for FY2006(06/06) is 21mm rev and 4.6mm net income. So 4.6mm net income / 18mm shares x 39 = $10
Current revenue and earnings projection for FY2007(06/07) is 124mm rev and 59mm net income. Using a forward PE of 20. So 59mm net income / 18mm shares x 20 = $65.
Remember that MLTO is going to up guidance for FE2006.
MLTO is worth far more than $10 and something less that $65, as FE2007 is a long way way.

Using Value per client: Industry practice is value based on 3-4 year revenue from customer. Industry is usually 3000-3500. MLTO thinks their customer is valued at 5000.
FY2006 customer count of 52,000 gives a market cap of 260mm. 260mm/18mm = $12.50
YE2006 (12/06) customer count of 72,000 gives a market cap of 360mm. 360mm/18mm = $20
FY2007 (06/07) customer count of 144,000 gives a market cap of 720mm. 720mm/18mm = $40

Market Share
At FY2006, looking to see 3%.
Mgmt and shareholders should expect 8-10% (400,000)

Reserve for doubtful accounts
Currently allocating 7% of revenue to doubtful accounts, but actually less than that.
Initital figures were very high because auditors requested all copay (20%) be allocated as doubtful, as given in the early numbers from June-Sept 2005.




Wow. Lots of stuff to digest.
Hope this helps. It sure helped me. :)

My table of monthly numbers from MLTO:

Some info is no longer provided. I started tracking the Patient Hold Journal in Dec-05.

 
 Month          Jul-05	Aug-05	Sep-05	Oct-05	Nov-05	Dec-05	Jan-06 
 Gross Billings	83658	145984	304621	418406	540114	596717	804949 
 % Change Prior Mo	75%	109%	37%	29%	10%	35% 
  
 New Patients		638	1304	1561	2030	2441	3186 
 Gross Margins	68	74	74	77	77	78	78 
 Patient Hold Journal					3213	4106 
 Patient Orders		1150	3108				 
 Call Volume	1459	1956	3772				 
 

Probably Eric Estrada,... LOL I've seen him on some other infomercials.

Edward James Olmos would be great too. He's great in Battlestar Galactica.

I don't think they can afford JLo or Mariah

Profit strategy question...

What is your strategy for taking profits in situations as what has happened to MLTO? i.e. big spikes.

I hesitated too long to put in a partial sell at 9, but I think that 8 is too low, although still a big gain.

thanks!

doubloon, et.al.:

I want to know what the charge off numbers look like.

While the 80% govt. Medicare payments would eventually get paid, the remaining 20% is the responsibility of the customer.

With 70-80% gross margins that's still not too shabby, but sure would like to see the net numbers.

Sounds like TDYH is getting out of the oil business.

Could be that this was the business plan all along ...

What is the strategy here?
Sell or
wait for a better offer?

I'm inclined to sell out...

PV10 on the web site was $258MM. That was with $40 oil and $5 mcf gas.

Certainly higher than the new $230MM with $63 oil and 13.63 mcf.

However, PV10 of 230MM is nothing to sneeze at, along with any new developments that TDYH may have.

Doubloon:

Some time ago you posted a couple of messages about O&G Trusts. Can you post the symbols again and any insights?

thank you!